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Summary.-Female rats were maintained on standard laboratory diet, Miller's diet
or Miller's diet containing 3'MeDAB. Animals fed standard or Miller's diet did not
excrete a-foetoprotein (AFP) in their urine. Early appearance of AFP was demon-
strated by examining the urine of rats on the 3'MeDAB regimen. The incidence of
positive urine samples was high between the 5th and 7th week of the experiment.
Itthereafter declined, butfrom the3rd month it steadily rose and reached a maximum
of 80% at about 10 months. Though urinary excretion of AFP was irregular in
individual animals, several positive urine samples were obtained from all rats
followed for more than a few months. The urine of 90% of hepatoma-bearing rats
contained AFP at the time of killing. The incidence of elevated serum AFP levels,
as determined by immunodiffusion, increased with the duration of the experiment,
but was still only 70% in rats fed 3'MeDAB for over 34 weeks. The severity of the
hepatic alterations, as well as hepatocytic uptake of [3H]thymidine, increased with
time. The serum of animals fed the standard diet was negative, whereas AFP was
very infrequently detected in the serum of rats given Miller's hypoprotein diet.
The results demonstrate that, in a population exposed to a hepatocarcinogenic agent,
the recurring detection of urinary excretion of AFP is a useful indicator of the high
risk of developing hepatomas.
Alpha-foetoprotein (AFP) has been
detectedbyOuchterlony's doubleimmuno-
diffusion technique in the urine of almost
two thirds of hepatoma-bearing rats
(Okon et at., 1973; Rosenmann et al.,
1974b), while demonstration ofits presence
in the serum has been achieved at a higher
incidence (Stanislawski-Birencwajg, Uriel
and Grabar, 1967; Okon et al., 1973).
Early appearance ofAFP in the serum has
been noted within 3 to 4 weeks of starting
the animals on the carcinogenic regimen
(Becker and Sell, 1974; Kroes, Williams
and Weisburger, 1972; Watabe, 1971).
Recent comprehensive reviews on AFP
summarize our knowledge about this
carcinofoetal antigen (Lamerz and Fateh-
Moghadam, 1975; Wepsic and Sell, 1974).
The purpose of the present communi-
cation is to describe the pattern of
urinary excretion of AFP in rats exposed
to 3'-methyl-4-dimethylaminoazobenzene
(3'MeDAB). The rationale of the study
is to establish the feasibility ofpredicting,
by repeated urine examinations, the
development ofhepatomas in a population
at high risk. The demonstration of AFP
in the urine of hepatoma patients (Cohen,
Starkovs and Olweney, 1975) lends rele-
vance of this investigation to clinical
medicine. It should be mentioned, by
way of introduction, that female rats of a
local strain in which hepatocarcinogenesis
is protracted, were used in order to
$ Present address: The Department of Endocrinology, Weizmann Institute of Science, Rehovot, Israel. Correspondence to: J. H. Boss, M.D., Department of Pathology, Hebrew University, Hadassah Medical
School, P.O. Box 1172, Jerusalem, Israel.ALPHA-FOETOPROTEIN IN RATS EXPOSED TO CARCINOGEN
substantiate better the value of urine
examinations repeated during a compara-
tively long period of time.
MATERIALS AND METHODS
Animals.-Female albino rats of the
Hebrew University (Sabra) strain, aged 60
days at the beginning ofthe experiment, were
used. In Group I, 56 rats were given
Amrod's standard laboratory diet (Ambor-
Yissum, Jerusalem), comprising 18-6% pro-
tein (Boss, Rosenmann and Zajicek, 1976a).
Group 2 had 84 rats fed Miller's diet (Miller
et al., 1948). Group 3 had 105 animals
maintained on Miller's diet to which was
added 0.06% of 3'methyl-4-dimethylamino-
azobenzene (3'MeDAB).
Production of antisera.-Antisera were
raised in rabbits against rat amniotic fluid
(AF) and embryonic serum(ES) as described
previously in detail (Okon et al., 1973).
Following absorptions with lyophilized blood
and an organ pool of healthy adult rats, the
antisera to AF and ES were found to contain
one and two precipitating antibodies, which
'were specific for AFP and for AFP plus alpha-
macrofoetoprotein (AMFP) respectively
(Boss, Dishon and Rosenmann, 1975).
Collection and testing of urine and serum
samples-.The rats were put in metabolism
cages over urine-faeces separators and 24 h
urine samples were collected from individual
animals at 2- to 4-week intervals. The
samples were concentrated to 5-10 mg of
non-dialyzable material per ml and reacted
against the antisera to AF and ES by
Ouchterlony's double immunodiffusion tech-
nique (Okon et al., 1973). Two to 5 rats of
each of the 3 groups were killed at about 3-
week intervals and blood was obtained by
exsanguination. The sera were reacted
against both antisera. A specimen giving
one precipitin linewith anti-AF antiserum and
two bands with anti-ES antiserum was
considered to contain AFP as well as AMFP.
When a single band developed with anti-
ES antiserum and no reaction occurred with
anti-AF antiserum, the sample was scored
positive for AMFP only. Urine containing
AFP produced a single line when tested with
either antiserum, since the high molecular
weight AMFP does not pass the normal
glomerular filter (Rosenmann et al., 1974b).
The plates were observed for 3 days, washed
in saline, stained with amido black and
rechecked.
Morphological examinations.-Two hours
prior to killing, 100 ,uCi oftritiated thymidine
([3H]TdR, 5 Ci/mM, Amersham) in 0 5 ml of
saline was injected i.p. Liver specimens
were fixed in Bouin's solution. Sections
were cut at 6 ,um and stained with haema-
toxylin and eosin. Consecutive sections
were coated xvith Ilford K-5 liquid emulsion,
exposed for 14 days, developed in Kodak
D-19, and stained with haematoxylin and
eosin. The number of labelled nuclei of
hepatocytes was counted in 50 successive
high power fields (HPF). Labelled nuclei of
sinusoidal, inflammatory, fibroblastic, ductal
and oval cells were not counted. The
histological evaluation was carried out by one
of the authors (J.H.B.), who had no know-
ledge of the results of the serological tests.
All the data were collected on IBM cards and
the computations were made aftertermination
of the experiments.
RESULTS
Alpha-foetoprotein was not detected
in over 1400 urine specimens obtained
from rats fed the standard laboratory
chow or Miller's diet. The results of the
examination of the 1142 urine samples
collected from the 105 rats maintained on
Miller's diet containing 3'MeDAB are
graphically presented in Fig. 1. The
ciphers denote the number of samples
obtained within each period of 20 days,
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Fit.. 1. Incidence ofurine specimens contain-
ing AFP in rats fed hepatocarcinogenic diet
(3' MeDAB). The ciphers indicate number
of samples tested at 20-day intervals. All
animals were 60 days old at the beginning
of the experiment.
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while the proportion of specimens con-
taining AFP is expressed as percentage of
number tested at these intervals. Urin-
ary excretion of AFP was not demon-
strated during the first month of the
experiment. While 35U0 of the urine
samples were positive between the 30th
and 50th day, the incidence of AFP
excretion decreased to less than 200%
between the 70th and 110th day. The
difference between the prevalence of early
excretion of AFP and the smaller number
of positive samples obtained during the
third and fourth month is statistically
significant (P < 0.002). By the 5th
month of the experiment, a steady
increase in positive urine specimens was
noticed, as seen by the linear regression in
Fig. 1. The results of the tests recorded
between the 110th and 390th day were
approximated by a straight line. The
correlation coefficient (r) between these
results and the age of the rats at testing
is 0-86, indicating that the increase in
positive urine samples with time is highly
significant. AFP was detected in about
7500 of urine specimens obtained from
animals fed 3'MeDAB for 42 or more
weeks. As expected, AMFP could not be
demonstrated in the urine, functional
impairment of the glomerular filter not
being evident in hepatoma-bearing rats.
The results of the examination of the
sera for the presence of AFP and AMFP
are summarized in the Table. The animals
were divided into 4 groups according to
the age at death, and the results are
expressed as the percentage of positive
sera obtained at 100-dav intervals. Sera
of rats fed the standard laboratory chow
were devoid of AFP: AMFP was detected
in 23-50% of the specimens. Five of the
84 sera obtained from rats given Miller's
diet contained AFP, while AMFP was
found in 27-71% of the samples. The
difference between the incidence of AMFP
in the sera ofrats fed Miller's diet and that
in the animals maintained on the regular
chow was statistically significant in the
301-400 days group (t - 2-34, P < 0.02).
The presence ofAMFP in many sera ofthe
control rats was related to diverse inter-
current diseases, prime among which was
interstitial pneumonia, AMFP being ident-
ical with acute phase protein (Boss et al.,
1975). The sera of the rats fed 3'MeDAB
for less than 40 days did not contain AFP
in amounts detectable byimmunodiffusion.
AFP was found in 26%, 48% and 70%
of the sera of the animals on the hepato-
carcinogenic regimen for 41-140, 141-240
and 241-340 days, respectively. The
differences in the incidence of AFP
between rats fed the carcinogenic agent
for 141-240 and for 40 days or less, as well
as between animals on the regimen for
241-340 and 41-140 days, were statisti-
cally significant (t 2-57, P < 0-02 and
t - 3 39, P < 0 001, respectively). The
prevalence of AMFP in the serum of these
rats increased from 38% at the interval of
0-40 days to 86% at the interval of 241-
340 days. At the time intervals of 41-
140 and 241-340 days, the difference
between the incidence of AMFP in the
serum of rats fed 3'MeDAB in Miller's
diet and that of animals given Miller's
diet only was statistically significant
(t 2-38, P < 0-02 and t 3K56, P <
0.001, respectively).
Histologically, the livers of rats fed
the standard laboratory or Miller's diet
were essentially normal. Small, round,
intralobular aggregates of mononuclear
cells were observed in the liver of many
animals, this being a common occurence
in our normal rat colony (Boss, Silber and
Nelken, 1967). Macroscopical and micro-
scopical hepatic alterations increased in
severity with time in the rats maintained
on the carcinogenic diet. The alterations
occurring during 3'MeDAB-induced hepa-
tocarcinogenesis being well known, only
the salient findings will herein be com-
mented upon in brief. The following
6 morphologic parameters were evaluated
semiquantitatively on an arbitrary scale
from 0 to 3+: portal tract fibrosis pro-
gressing to cirrhosis, inflammatory infil-
tration, parenchymal cellular unrest, oval
cell hyperplasia, areas of atypical paren-
chyma and atypical regenerative nodules.
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FIG. 2. Cellular disturbance ofliver parenchyma. The nuclei vary in shape, size and staining proper-
ties, and contain one or more prominent nucleoli. Note clear cytoplasm of many hepatocytes.
H. and E. x 420.
FIG. 3.-Oval cell hyperplasia. Enlarged portal tract, disclosing inflammatory infiltration and proliferation
of oval cells at its margin. H. and E. x 420.ALPHA-FOETOPROTEIN IN RATS EXPOSED TO CARCINOGEN
In order to assess the severity of the
alterations in individual animals, the
histology index (HI) was calculated by
summing up the scores of each of the 6
features, the highest possible HI in any
one case being 18. The arithmetic mean
of the Hlis was computed for the animals
killed betweenthe ages of60-100, 101-200,
201-300 and 301-400 days. A few repre-
sentative examples should suffice to clarify
the criteria employed for the histological
evaluation. Moderatefibrosis was charac-
terized by enlargement ofthe portal tracts
and formation of connective tissue septa,
which were infiltrated by a mixed in-
flammatory, predominantly lymphocytic
cell population. With merging ofadjacent
septa, a cirrhotic pattern ensued. The
hallmark of cellular disturbance was the
variation in size and shape of the hepato-
cvtes and their nuclei, some of the latter
being hyperchromatic and others con-
taining one or more prominent nucleoli;
many large hepatocytes had a clear
cytoplasm (Fig 2). The number of bile
ducts was increased in the more advanced
lesions, while oval cell hyperplasia was an
early and consistent finding. Oval cell
hyperplasia was particulary discernible
at the lobular periphery, showing accumu-
lation ofsmall, elongated cells with plump
oval nuclei, having a rather delicate
chromatin network and an inconspicuous
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FIG. 4.-Graphic representation of increasing
severitv ofcombined hepatic changes (Hist-
ology Index) with duration of exposure to
the hepatocarcinogenic regimen.
nucleolus (Fig. 3). Cirrhotic livers were
generally the site of areas of atypical
parenchyma and atypical regenerative
nodules. Such nodules were well circum-
scribed, compressing the adjacent paren-
chyma, and their cells exhibited marked
pathology and often a clear cytoplasm.
The increase in the HI with the
duration of the experiment is graphically
represented ini Fig. 4. The HI increased
from 3.5 in rats kept on the hepato-
carcinogenic diet for less than 40 days
(i.e., 61-100 days old) to 13 in animals
killed at the age of 301-400 days. The
differences between the mean HIIs of rats
killed at the 4 time intervals were statis-
tically significant (101-200/60-100, P <
002; 201-300/101-200, P < 0-001; and
301-400/201-300 P < 0-02). The mean
HI of rats whose serum contained AFP
was 13 2 + 0-5, and that of animals in
whose serum AFP could not be detected
was 6-6 ± 0-5. The difference between
the HIs ofthe AFP-positive and the AEP-
negative cases was statistically significant
(t = 9-6, P < 0001).
Hepatomas developed in 11 of the 74
rats fed 3MeDAB for 140 days or longer.
The tumours were either of the hepato-
cellular or mixed hepatocellular and
tabular variety (Fig. 5). The mean age of
hepatoma-bearing rats was 277 + 12 days
and the average HI was 14-9 ± 0-7.
The serum of 10 of the 11 animals con-
tained AFP, and 8 urine samples were
positive on the day before they were killed.
The number of hepatocytic nuclei
labelled with [3H]TdR per 50 HPF in the
livers of rats fed the standard laboratory
(control), Miller's or hepatocarcinogenic
diet is illustrated graphically in Fig. 6.
Uptake of TdR was not evident in about
half of the animals maintained on the
standard diet. In the other half, 1-3
labelled nuclei per 50 HPF were generally
counted, while 4-12 labelled nuclei were
found in exceptional cases. TdR uptake
was considerably higher in the livers of
animals fed Miller's diet than in those of
rats given the regular chow (t = 4-1,
P < 0001). Moreover, though up to
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FIG. 5.--Mixed hepatocellular and tabular carcinoma. H. and E. X 105.
3 labelled cells per 50 HPF were pre,
about 4000 of the sections scrutini.
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FIG. 6. Graph showing uptake (
by hepatocyte nuclei in livers of
standard (control), Miller's or
cinogenic (3'MeDAB) diet.
was significantly higher in rats given the
hepatocarcinogenic diet for 41 days or
longer than in animals fed Miller's diet.
In the latter, the total average of labelled
nuclei per 50 HPF was 7-7+0 9. In the
rats fed 3'MeDAB for 41-141 days the
average number of labelled nuclei was
MeDAB 16-0 + 4-4. Thus the difference in TdR
uptake between the 2 groups was statisti-
cally significant even for this time interval
(t 2-3, P < 0.05). TdR uptake in the
rats on the carcinogenic regimen increased
with the duration of the experiment, the
correlation coefficient between the number
of [3H]TdR-labelled hepatocytes and age
Miller being 0-66 (P < 0*01).
DISCUSSION
300 400 The results of the investigation de-
scribed here demonstrate that examination
Iof [3H]TdR of the urine for AFP complements that of
rats fed the serum. Using the double immunodif-
hepatocar- fusion technique, AFP was occasionally
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detected in the concentrated urine of an
animal the serum of which was negative.
During the follow-up of rats fed the
hepatocarcinogenic diet, urine specimens
wererepeatedlytested, whilea single serum
sample was obtained. Unexceptionally,
2, and generally more, positive urine
samples were obtained from each animal
exposed to the carcinogenic agent for
more than a few weeks. The variability
between individual rats was conspicuous,
in that only an occasional positive urine
sample was obtained from some rats,
whereas many and consecutive specimens
collected from other animals were found to
contain AFP. In the majority of
instances, AFP was detected several times
at irregular intervals. It remains to be
established whether these findings are
accidental, or reflect quantitative dif-
ferences in AFP synthesis by individual
rats of the semi-inbred Sabra strain.
Whenthe pattern ofurinaryAFPexcretion
during the period of exposure to the hepa-
tocarcinogen was retrospectively evalu-
ated, it was concluded that it would have
been impossible to predict which rats had
tumours at the time of death. However,
2 points deserve to be stressed. First,
in this and in our previous study (Okon et
al., 1973), massive involvement ofthe liver
by neoplastic nodules is generally associ-
ated with positive urine samples. Second,
since the rats were randomly killed, it is
reasonable to assume that hepatomas
might have eventually developed as
3'MeDAB induces tumours in practically
all of our animals, provided the period of
exposure islongenough. Theimplications
of this experiment are self-evident. It
appears to us that a screening test of the
urine, carried out at regular intervals, may
be ofdiagnostic aid in a population at high
risk. It is simpler and more agreeable
to both patient and medical personnel to
have urine checked repeatedly than to
have blood drawn time and again. That
the test is applicable to man has been
recently evinced in hepatoma patients
(Cohen et al., 1975).
AFP was detected in the urine of some
rats as early as the 4th week of the
experiment, whereas it was not found in
the serum prior to the 4th month. This
discrepancy is explicable in view of the
fact that the urine was concentrated about
ten-fold, and often higher, prior to testing
(Okon et al., 1973). Moreover, it is
feasible that the renal tubular apparatus
concentrates AFP relative to other low-
molecular-weight plasma proteins passing
the glomerular filter. It is ofinterest that,
in rats which had been on the oncogenic
regimen for over 7 months, the prevalence
of positive urine and serum tests was
similar.
It is possibly of diagnostic as well as
prognostic significance that positive urine
specimens were found at a relatively high
incidence (35%) in rats fed 3'MeDAB for
4-6 weeks. In fact, a positive urine was
discovered in a rat exposed to the carcino-
genic agent for only 25 days. Excretion
of AFP was detected at a lower incidence
(20%) between the 10th and 14th week.
Thereafter, the prevalence of AFP-
containing urine specimens rose steadily,
approximating 750o after 9 months.
AFP was detected in the serum of 10 of
the 11 hepatoma-bearing rats, several
urine specimens of which were positive
some time prior to killing.
The early appearance of AFP in the
serum of rats fed one or other hepato-
carcinogen waspreviouslyreported (Becker
and Sell, 1974; Kroes, Williams and
Weisburger, 1972; Kroes, Williams and
Weisburger, 1973; Watabe, 1971). Ac-
cording to Watabe (1971), 75%o of the
sera of rats fed 4-DAB for 6 weeks con-
tained AFP. The serum concentration
ofAFP subsequently decreased and a late-
stage appearance occurred after 13 weeks.
Watabe's observations are confirmed by
the present investigation, in which en-
hanced production of AFP was, however,
assessed by urine examinations. The
decline in the incidence of positively
reacting specimens, whether serum or
urine, following an initial high peak, is
poorly understood. We could find no
unequivocal evidence to suggest that,
107J. H. BOSS, G. ZAJICEK, E. OKON AND E. ROSENMANN
though AFP is synthesized in increased
amounts, being complexed with circu-
lating antibodies, it cannot be detected in
the body fluids. We are inclined to agree
with Watabe (1971) that the early appear-
ance of AFP may reflect hepatocellular
proliferation consequent upon acute liver
injury caused by the toxic effect of
3'MeDAB. That production of AFP is
indeed coupled to cell division in the
regenerating liver (Sell et al., 1974) is
supported by the association of elevated
serum AFP levels with increased TdR
uptake in the livers of rats dosed with
different hepatotoxic agents (Boss and
Rosenmann, 1976). In these experiments,
AFP was detected in the sera ofrats killed
2-3 days after a single injection of thio-
acetamide, carbon tetrachloride, beryllium
sulphate or cadmiun chloride. It should
be mentioned in this context that the
incidence ofAFP-containing urine samples
slightly lower during hepatocarcinogenesis
than during the development of cirrhosis
induced by chronic exposure to carbon
tetrachloride, the latter being cirrhoto-
genic but not carcinogenic in the female
Sabra rat (Boss, unpub.).
The hepatic changes progress with the
duration of exposure to 3'MeDAB in
accordance with a consistent pattern,
though individual variations in their
severity are conspicuous. An attempt
has been made inthe present investigation,
to assess the progression by semiquanti-
tatively evaluating the extent and inten-
sity of 6 well-established parameters.
The uptake of [3H]TdR has been con-
comitantly determined by counting the
number of labelled hepatocytic nuclei in
50 HPF. There is a good correlation
between the progression of the hepatic
disorder and increased TdR uptake on the
one hand, and the rising incidence ofAFP-
containing serum and urine specimens on
the other. These observations are in
agreement with the reports of other
investigators (Dolezalova et al., 1974;
Watabe, 1971). However, in contrast to
the findings of these and other authors
(Stanislawski-Birencwajg et al., 1967), we
have succeeded in demonstrating, by the
immunodiffusion test, the appearance of
AFP in all rats fed the hepatocarcinogenic
diet for several months, whether tumours
eventually developed or not. The likeli-
hood of encountering a positive sample is
probably enhanced by repeatedly examin-
ing the urine of the same animals over a
long period of time. Furthermore, we
disagree with the notion that increased
production of AFP does not occur during
the stage of nodular hyperplasia (Kita-
gawa, Yokochi and Sugano, 1972). In
fact, urinary excretion of AFP has been
demonstrated when no hepatoma was
found, but nodular hyperplasia was pre-
sent. It is of note in this context that
localization of AFP has been shown in
hyperplastic liver nodules developing
during carcinogenesis induced by 2-
acetylaminofluorene (Okita, et al., 1974).
It is unexpected, at first sight, that
AFP was detected by the immuno-
diffusion technique, in 5/84 rats fed
Miller's diet. Similar observations have
been reported by DeNechaud and Uriel
(1973) and ascribed to the development of
liver damage in animals maintained for
long periods oftime on Miller's low protein
diet. The appearance of AFP appears to
correspond to the slightly but significantly
greater uptake of TdR by the livers of
animals given Miller's dietthan bylivers of
rats kept on the standard chow. Liver
injury accompanied by enhanced AFP
production is known to occurin deficiencies
other than those due to a hypoprotein
diet, having been described in monkeys
maintained on a pyridoxine-deficient diet
(Foy et al., 1970) and rats on a choline-
deficient diet (Boss, Rosenmann and
Zajicek, 1976a).
The results presented herein further
contribute to our efforts to establish the
value of the urine examination for the
presence ofnon-plasma proteins (Boss et al.
1973). The determination of urinary
excretion of specific antigens, be they
hepatic, renal or tumoral, serves to draw
attention to the underlying pathological
process. In rats fed 3'MeDAB, examin-
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ation of urine at frequent intervals has
uncovered a characteristic pattern of AFP
excretion. In contrast to the transient
appearance of AFP in the urine of rats
with toxic liver damage induced, for
example, by thioacetamide or carbon
tetrachloride (Boss, Rosenmann and
Zajicek, 1976b), the excretion of AFP
persist8 in animals exposed to a hepato-
carcinogenic regimen. Many urine
samples were devoid of detectable AFP,
possibly because of the low sensitivity of
the immunodiffusion technique, low serum
AFP at the time of urine collection and/or
fluctuations of AFP synthesis. Be that
as it may, the findings indicate that
examination ofthe urine may complement
that of the serum. This could be of
special importance in populations at high
risk, in which frequent sampling is
desirable.
This investigation was supported by
grants from the Sam Spiro Trust, Beer-
Lehmsdorf Foundation and the Joint
Research Fund of the Hebrew University
and Hadassah Medical Organization.
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